PL3165223T3 - Zastosowanie 3-(3-[1,2,4]-triazolo)-oksatriazolium-5-olatu do leczenia zaburzeń seksualnych - Google Patents
Zastosowanie 3-(3-[1,2,4]-triazolo)-oksatriazolium-5-olatu do leczenia zaburzeń seksualnychInfo
- Publication number
- PL3165223T3 PL3165223T3 PL15815425T PL15815425T PL3165223T3 PL 3165223 T3 PL3165223 T3 PL 3165223T3 PL 15815425 T PL15815425 T PL 15815425T PL 15815425 T PL15815425 T PL 15815425T PL 3165223 T3 PL3165223 T3 PL 3165223T3
- Authority
- PL
- Poland
- Prior art keywords
- oxatriazolium
- olate
- triazolo
- sexual disorders
- treating sexual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014127279/15A RU2600845C2 (ru) | 2014-07-04 | 2014-07-04 | Применение производных оксатриазолий-5-олата для лечения сексуальных расстройств |
EP15815425.2A EP3165223B1 (en) | 2014-07-04 | 2015-07-01 | Use of 3-(3-[1,2,4]-triazolo)-oxatriazolium-5-olate for treating sexual disorders |
PCT/RU2015/000413 WO2016003327A1 (ru) | 2014-07-04 | 2015-07-01 | Применение 3-(3-[1,2,4]-триазоло)-оксатриазолий-5-олата для лечения сексуальных расстройств |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3165223T3 true PL3165223T3 (pl) | 2020-01-31 |
Family
ID=55019709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15815425T PL3165223T3 (pl) | 2014-07-04 | 2015-07-01 | Zastosowanie 3-(3-[1,2,4]-triazolo)-oksatriazolium-5-olatu do leczenia zaburzeń seksualnych |
Country Status (7)
Country | Link |
---|---|
US (1) | US9795593B2 (pl) |
EP (1) | EP3165223B1 (pl) |
EA (1) | EA032337B1 (pl) |
ES (1) | ES2747995T3 (pl) |
PL (1) | PL3165223T3 (pl) |
RU (1) | RU2600845C2 (pl) |
WO (1) | WO2016003327A1 (pl) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3911668A1 (de) | 1989-04-10 | 1990-10-11 | Cassella Ag | Substituierte 1.2.3.4-oxatriazolium-5-olate, verfahren zu ihrer herstellung und ihre verwendung |
DE10222550A1 (de) | 2002-05-17 | 2003-11-27 | Bayer Ag | Substituierte Benzyl-pyrazolopyridine |
WO2005023189A2 (en) | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
WO2006055542A2 (en) | 2004-11-15 | 2006-05-26 | Nitromed, Inc. | Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
EP1925307A1 (en) | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
WO2008087177A1 (en) | 2007-01-18 | 2008-07-24 | Neurosearch A/S | Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators |
RU2351328C1 (ru) * | 2007-08-02 | 2009-04-10 | Общество с ограниченной ответственнотью "Консорциум-ПИК" (ООО "Консорциум-ПИК") | Гипотензивное средство 3-(3-[1,2,4]-триазоло)-оксатриазолий-5-олата длительного действия |
SG186369A1 (en) | 2010-06-25 | 2013-01-30 | Horphag Res Ip Pre Ltd | Composition for improving sexual wellness |
KR101189108B1 (ko) | 2011-12-29 | 2012-10-10 | 재단법인 전라남도생물산업진흥재단 | 황칠나무 추출물을 포함하는 남성 성기능 개선용 조성물 |
-
2014
- 2014-07-04 RU RU2014127279/15A patent/RU2600845C2/ru active
-
2015
- 2015-07-01 PL PL15815425T patent/PL3165223T3/pl unknown
- 2015-07-01 EP EP15815425.2A patent/EP3165223B1/en active Active
- 2015-07-01 WO PCT/RU2015/000413 patent/WO2016003327A1/ru active Application Filing
- 2015-07-01 EA EA201700038A patent/EA032337B1/ru not_active IP Right Cessation
- 2015-07-01 ES ES15815425T patent/ES2747995T3/es active Active
- 2015-07-01 US US15/323,567 patent/US9795593B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2747995T3 (es) | 2020-03-12 |
EP3165223A4 (en) | 2017-07-26 |
RU2600845C2 (ru) | 2016-10-27 |
WO2016003327A9 (ru) | 2016-02-11 |
US20170202809A1 (en) | 2017-07-20 |
EP3165223B1 (en) | 2019-06-26 |
EA201700038A1 (ru) | 2017-07-31 |
WO2016003327A1 (ru) | 2016-01-07 |
EP3165223A1 (en) | 2017-05-10 |
RU2014127279A (ru) | 2016-01-27 |
US9795593B2 (en) | 2017-10-24 |
EA032337B1 (ru) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257222A1 (zh) | 經巴氏滅菌的艾克曼菌用於治療代謝病症的用途 | |
IL247841A0 (en) | Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma | |
IL250960A0 (en) | Combined treatment of sinecriviroc for the treatment of leprosy | |
HK1232147A1 (zh) | 用於治療纖維化的賽尼克韋羅 | |
HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
IL253197A0 (en) | Methods for the treatment of sphingosine-1-phosphate receptor 1-related conditions | |
IL250838A0 (en) | Devices for the treatment of heart failure | |
PT3119911T (pt) | Compostos para uso no tratamento da doença de alzheimer em pacientes apoe4+/+ | |
IL251616A0 (en) | Methods and compounds for the treatment and prevention of muscle loss | |
PT3160464T (pt) | 6-hidroxibuspirona para uso no tratamento de transtornos do movimento | |
SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
EP3200795A4 (en) | Use of agents for treating fat-related disorders | |
PL3165223T3 (pl) | Zastosowanie 3-(3-[1,2,4]-triazolo)-oksatriazolium-5-olatu do leczenia zaburzeń seksualnych | |
GB201506228D0 (en) | Methods For The Treatment Of Cardivascular Disorders | |
GB201602784D0 (en) | New treatment of CFTR-related disorders | |
GB201521543D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201413532D0 (en) | Combination therapy for treating hearing disorders | |
GB201513993D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201513345D0 (en) | Methods for the treatment of Inflammatory disorders | |
GB201507113D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201506419D0 (en) | Methods for the treatment of inflammatory disorders | |
GB201506229D0 (en) | Methods For the Treatment Of Inflammatory Disorders |